| Literature DB >> 31991560 |
Mariangela Rondanelli1,2, Chiara Rigon3, Simone Perna4, Clara Gasparri3, Giancarlo Iannello5, Rashida Akber4, Tariq Abdulkarim Alalwan4, Afnan Mahmood Freije4.
Abstract
Sarcopenia is defined as a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength and it is diagnosed by measurements of muscle mass, muscle strength, and physical performance. Sarcopenia affects quality of life and is associated with several adverse health effects. Muscle decline is aggravated by a sedentary lifestyle and can be prevented through proper nutrition, together with adequate physical activity. Fish contains biologically active compounds, such as omega-3 polyunsaturated fatty acids, proteins, vitamin D, magnesium, and carnitine, which are able to intervene positively on muscle metabolism. This narrative literature review was performed to evaluate evidence regarding the actual benefit of fish consumption in the prevention of sarcopenia and the positive action on the muscle mass of the biological compounds present in fish. The results demonstrated that fish consumption has a protective and anti-inflammatory function on skeletal muscle and that its biologically active compounds help to maintain good muscle performance, preventing sarcopenia. Considering the nutritional and health benefits, elderly with sarcopenia should consume at least three servings per week of fish in order to have a minimum intake of 4-4.59 g daily of omega 3, and reaching the 50% RDA in Vitamin E and D. High biological value of proteins in 150 g of fish and its high available magnesium (20% of RDA in 150 g of fish) are an added value that could suggest fish as a "functional food" in order to prevent and treat sarcopenia.Entities:
Keywords: anti-inflammatory; fish; muscle mass; sarcopenia
Year: 2020 PMID: 31991560 PMCID: PMC7071242 DOI: 10.3390/nu12020307
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Summary of studies of omega-3 fatty acids considered in this narrative review.
| Authors/Title/Year | Type of Study | Oil Integration | Sample | Duration | Results |
|---|---|---|---|---|---|
| Smith et al. 2015 | Randomized study | n-3 PUFA (1.86 EPA and 1.50 g DHA/die) or corn oil | Sixty healthy 60–85-year-old men and women | Six months | Treatment with fish oil derived n-3 PUFA brought benefits on thigh muscle volume, handgrip strength, and tended to increase the average isokinetic leg muscle power |
| Yoshino et al. 2016 | Ten subjects of Smith study (2015) with best answer to treatment | n-3 PUFA (1.86 EPA and 1.50 gDHA/die) or corn oil | Twenty healthy 60–85-year-old men and women | Six months | Different pathways involved in mitochondrial regulation and in the organization of the cell matrix were increased while the pathways related to calpain- and ubiquitin-mediated proteolysis, mRNA translation, and inhibition of mTOR signaling were decreased |
| Rodacki et al. 2012 | Randomized study | 3 groups: Group ST (only strength-training), Group ST90 (2 g/die fish oil for 90 days) and ST150 (2 g/die fish oil for 150 days) | Forty-five women | 90 or 150 days | Supplementation with fish oil accompanied by strength training increased the neuromuscular system, enhancing the muscle strength and the functional capacity in elderly women |
| Boit et al. 2017 | Randomized study | 3 g of fish oil | Fifty men and women | 18 weeks | long-chain n-3 PUFA supplementation enhances the increases in maximal isometric torque and muscle quality after 18 weeks of resistance exercise in older women but not in older men |
| Smith et al. 2011 | Randomized study | n-3 PUFA (1.86 EPA and 1.50 g DHA/die) | Sixteen healthy adults | 8 weeks | Omega 3 PUFA enhance muscle protein synthesis in response to stimulated feeding |
| McGlory et al. 2016 | Randomized study | Fish oil group (5 g/day fish oil) and CONTROL GOUP (5 g/day coconut oil) took proteins following resistance exercise. | Twenty healthy males | 8 weeks | No changes were found neither at REST, nor after physical activity (FED) nor after physical activity + protein intake (FEDEX) |
| Pahor et al. 2018 | Pilot randomized clinical trial | 0.7 of fish contained 400 mg of EPA and 200 mg of DHA | 289 participants with reduced mobility | 12 months | found no significant changes on IL-6 or walking speed |
| Kamolrat et al. 2013 | Randomized study | Two group: fish oil (EPA 49.6%, DHA 50.4%) and control oil (60% olive and 40 & soy) | 32 male Rowett strain Lister Hooded rats | 8 weeks | The results also indicate an increase in anabolic signalling pathways particularly in type 2 fibres without effects on inflammation processes |
| Gingras et al. 2007 | Randomized study | Two groups: control group (control oil mixture based on 60% cotton seed and 40% virgin olive oils), group LC | Six growing steers | 15 weeks | Long-term enteral the supply of LCn-3PUFA gives greater sensitivity to elimination of insulin-regulated amino acids and glucose and that these answers occur, in part, in the skeleton muscle |
| Kamolrat et al. 2013 | In vitro study | Three group of murine C2C12 cells: control, EPA group, and DHA group | Murine C2C12 murine cell | 28 h | The cells treated with EPA had greater protein synthesis and a lower protein breakdown than the controls and cells treated with DHA |
| Siam M, et al. 2008 | Retrospective cohort study | No | 2983 men and women aged 59 to 73 | Each additional portion of fatty fish consumed per week was associated with a gain in grip strength 0.43 kg in men and 0.48 kg in women. |
Summary of studies on fish protein considered in this narrative review.
| Type of Study | Protein Supplementation | Sample | Duration | Results | |
|---|---|---|---|---|---|
| Alexandrov Nikita et al. 2018 | Cohort Study | 31,278 men and 43,355 women of 18–91 years | The proteins of animal origin increase the secretion of carnitine, suggesting their ability to preserve muscle mass. | ||
| Drotningsvik A et al. 2019 | Double-blind randomized controlled pilot study | One intervention arm (5.2 g of whiting hydrolysate) and one control arm (placebo) | 24 nursing home residents (60 years or older) | 6 weeks | The study is feasible. |
Summary of studies on vitamin D considered in this narrative review.
| Type of Study | Vitamin D Supplementation | Sample | Duration | Results | |
|---|---|---|---|---|---|
| Antoneta Granic et al. 2017 | Newcastle 85+ study: longitudinal study | No supplementation vitamin D | 845 | 5 years | The lowest 25(OH)D season-specific quartile was associated with a faster rate of muscle strength decline in men 85+ years old |
| Mee Kyoung Kim et al. 2011 | Cross-sectional study | No supplementation vitamin D. Result extracted from study conducted periodically since 1998 to assess the health and nutritional status of the noninstitutionalized civilian population of Korea | 1380 men and 1789 women aged 50 years or older | From 1998 | Strong inverse association between 25(OH)D level and sarcopenia in older Koreans |
| Knutsen at al. 2010 | Cross sectional descriptive study | No supplementation vitamin D | 572 | 2 months | musculoskeletal pain, headache, fatigue is correlated with deficiency of vitamin D |
| Bischoff-Ferrari et al. 2004 | No supplementation vitamin D | 32 patients | Vitamin D receptors in muscle decrease with old age | ||
| Marieke B. Snijder et al. 2006 | Prospective cohort study | No supplementation vitamin D | 1231 men and women (aged 65 years and older) Amsterdam | 1 year | Low 25(OH)D (10 ng/mL) was associated with an increased |
| Bischoff-Ferrari et al. 2016 | Double-blind randomized clinical trial | Three study groups with monthly treatments: | 200 men and women (aged 70 years and older) | 1 year | Although higher monthly doses of vitamin D were effective in reaching a threshold of at least 30 ng/mL of 25-hydroxyvitamin D, they had no benefit on lower extremity function and were associated with increased risk of falls compared with 24,000 IU |
| J.H. Oh et al. 2009 | Two group: | No supplementation vitamin D | 366 patients | 16 months | Serum vitamin level had a significant negative correlation with fatty degeneration of the torn cuff muscles and a positive correlation with isokinetic muscle performance |
Summary of studies on magnesium considered in this narrative review.
| Authors/Title/Year | Type of Study | Magnesium Intake Measurement | Concentration Serum Magnesium Measurement | Sample | Duration | Results |
|---|---|---|---|---|---|---|
| Domingeuez Ligia J et al. 2006 | Prospective epidemiologic study | No | Yes | 1453 | 20 months | Higher levels of circulating magnesium correspond to better muscle performance |
| Welch Alisa A et al. 2016 | Cross-sectional study | Yes | No | 2570 women aged 18 to 79 years | Data extrapolated over the years from an ongoing study on the aging of healthy adult twins | High intake of magnesium is significantly associated with a higher percentage of Fat Free Mass (FFM), leg explosive power and with circulating CRP concentrations. |
| Welch Alisa A et al. 2017 | Prospective cohort study | Yes | No | 502,655 people aged 37–73 years | 2006–2010 | A greater magnesium intake was related to grip strength and a higher skeletal muscle mass. |
| Hayhoe Richard P.G. et al. 2019 | cross-sectional cohort study | Yes | Yes | 25,639 men and women aged 40–79 years old | 1993–2000 | A higher intake of magnesium and a higher serum magnesium concentration corresponded to better skeletal muscle mass indices in both men and women |
Creatine monohydrate.
| Authors/Title/Year | Type of Study | Supplementation Creatine | Sample | Duration | Results |
|---|---|---|---|---|---|
| Darren G. Candow. 2008 | Randomized double-blind study | Yes | 30 | 10 weeks | Low-dose creatine supplementation enhances lean mass end grip strength but did not lead to formaldehyde production. |
Summary of studies on l-carnitine considered in this narrative review.
| Authors/Title/Year | Type of Study | L-Carnitine Supplementation | Sample | Duration | Results |
|---|---|---|---|---|---|
| Sawicka Angelika K et al. 2018 | Randomized study | Yes | 28 | 24 weeks | Evident better preservation of lean mass in those taking L-carnitine. |
| Malaguarnera M. 2007 | Randomized, double-blind, placebo-controlled study. | Yes | 66 centenarians | 6 months | Patients taking L-carnitine had a reduction in fat mass and an increase in lean mass. |